Industry Research Reports
Home > Reports > Service & Software > Global Drug Release Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Drug Release Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-08-22
Pages: 109 Pages
Report ld: 4928373
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Drug Release Platform Market Size(US$)
CAGR 2025-2031
10.2%
Market Size,2031
USD 3,745
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,091 million
Market Forecast in 2031(Value)
US$ 3,745 million
CAGR
10.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Drug Release Platform market size was US$ 1901 million in 2024 and is forecast to a readjusted size of US$ 3745 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
A sustained-release drug platform is a technology system that achieves sustained, controlled, and targeted drug release in the body through specific carrier materials, formulation technologies, or intelligent release mechanisms. It can prolong the duration of drug action, improve bioavailability, reduce dosing frequency and side effects, and optimize therapeutic efficacy. Sustained-release drug platforms can be used for multiple routes of administration, including oral administration, injection, and local implantation. They serve a wide range of applications in chronic disease management, tumor treatment, vaccine delivery, and precision medicine, forming a crucial foundation for modern drug development and intelligent drug delivery technologies.
The North America Drug Release Platform market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Drug Release Platform include Evonik, Camurus, Pacira BioSciences, Starpharma, ProLynx, Liquidia, MedinCell, Intarcia, Corium, Enable Injections, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Drug Release Platform market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Evonik
- Camurus
- Pacira BioSciences
- Starpharma
- ProLynx
- Liquidia
- MedinCell
- Intarcia
- Corium
- Enable Injections
- Alkermes
- Depomed
- NanoCarrier
- Lyndra
- Hisun Pharmaceutical
- Livzon Pharmaceutical Group
- Hengrui Pharmaceuticals
- HEC ChangJiang Pharmaceutical
- Luye Pharma
- Lanna Bio
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Oral Sustained-Release Platform
- Implantable Sustained-Release Platform
- Local Sustained-Release Platform
Segment by Application
- Pharmaceutical Companies
- Hospitals
- Others
Segment by Category
- Diffusion-Controlled
- Degradation-Controlled
- Stimulus-Responsive
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drug Release Platform market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Implantable Sustained-Release Platform in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Release Platform value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Sustained-Release Platform
1.2.3 Implantable Sustained-Release Platform
1.2.4 Local Sustained-Release Platform
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Release Platform Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Drug Release Platform Revenue Market Share by Region (2020-2025)
2.4 Global Drug Release Platform Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Drug Release Platform Market Size and Prospective (2020-2031)
2.5.2 Europe Drug Release Platform Market Size and Prospective (2020-2031)
2.5.3 China Drug Release Platform Market Size and Prospective (2020-2031)
2.5.4 Japan Drug Release Platform Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Drug Release Platform Market Size and Prospective (2020-2031)
2.5.6 India Drug Release Platform Market Size and Prospective (2020-2031)
2.5.7 South America Drug Release Platform Market Size and Prospective (2020-2031)
2.5.8 Middle East Drug Release Platform Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Drug Release Platform Historic Market Size by Type (2020-2025)
3.2 Global Drug Release Platform Forecasted Market Size by Type (2026-2031)
3.3 Different Types Drug Release Platform Representative Players
4 Breakdown Data by Application
4.1 Global Drug Release Platform Historic Market Size by Application (2020-2025)
4.2 Global Drug Release Platform Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Drug Release Platform Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drug Release Platform Players by Revenue (2020-2025)
5.1.2 Global Drug Release Platform Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drug Release Platform Revenue
5.4 Global Drug Release Platform Market Concentration Analysis
5.4.1 Global Drug Release Platform Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drug Release Platform Revenue in 2024
5.5 Global Key Players of Drug Release Platform Head office and Area Served
5.6 Global Key Players of Drug Release Platform, Product and Application
5.7 Global Key Players of Drug Release Platform, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Drug Release Platform Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drug Release Platform Market Size by Type (2020-2025)
6.1.2.2 North America Drug Release Platform Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drug Release Platform Market Size by Application (2020-2025)
6.1.3.2 North America Drug Release Platform Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Drug Release Platform Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drug Release Platform Market Size by Type (2020-2025)
6.2.2.2 Europe Drug Release Platform Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drug Release Platform Market Size by Application (2020-2025)
6.2.3.2 Europe Drug Release Platform Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Drug Release Platform Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Drug Release Platform Market Size by Type (2020-2025)
6.3.2.2 China Drug Release Platform Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Drug Release Platform Market Size by Application (2020-2025)
6.3.3.2 China Drug Release Platform Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Drug Release Platform Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Drug Release Platform Market Size by Type (2020-2025)
6.4.2.2 Japan Drug Release Platform Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Drug Release Platform Market Size by Application (2020-2025)
6.4.3.2 Japan Drug Release Platform Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Drug Release Platform Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Drug Release Platform Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Drug Release Platform Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Drug Release Platform Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Drug Release Platform Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Drug Release Platform Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Drug Release Platform Market Size by Type (2020-2025)
6.6.2.2 India Drug Release Platform Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Drug Release Platform Market Size by Application (2020-2025)
6.6.3.2 India Drug Release Platform Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Evonik
7.1.1 Evonik Company Details
7.1.2 Evonik Business Overview
7.1.3 Evonik Drug Release Platform Introduction
7.1.4 Evonik Revenue in Drug Release Platform Business (2020-2025)
7.1.5 Evonik Recent Development
7.2 Camurus
7.2.1 Camurus Company Details
7.2.2 Camurus Business Overview
7.2.3 Camurus Drug Release Platform Introduction
7.2.4 Camurus Revenue in Drug Release Platform Business (2020-2025)
7.2.5 Camurus Recent Development
7.3 Pacira BioSciences
7.3.1 Pacira BioSciences Company Details
7.3.2 Pacira BioSciences Business Overview
7.3.3 Pacira BioSciences Drug Release Platform Introduction
7.3.4 Pacira BioSciences Revenue in Drug Release Platform Business (2020-2025)
7.3.5 Pacira BioSciences Recent Development
7.4 Starpharma
7.4.1 Starpharma Company Details
7.4.2 Starpharma Business Overview
7.4.3 Starpharma Drug Release Platform Introduction
7.4.4 Starpharma Revenue in Drug Release Platform Business (2020-2025)
7.4.5 Starpharma Recent Development
7.5 ProLynx
7.5.1 ProLynx Company Details
7.5.2 ProLynx Business Overview
7.5.3 ProLynx Drug Release Platform Introduction
7.5.4 ProLynx Revenue in Drug Release Platform Business (2020-2025)
7.5.5 ProLynx Recent Development
7.6 Liquidia
7.6.1 Liquidia Company Details
7.6.2 Liquidia Business Overview
7.6.3 Liquidia Drug Release Platform Introduction
7.6.4 Liquidia Revenue in Drug Release Platform Business (2020-2025)
7.6.5 Liquidia Recent Development
7.7 MedinCell
7.7.1 MedinCell Company Details
7.7.2 MedinCell Business Overview
7.7.3 MedinCell Drug Release Platform Introduction
7.7.4 MedinCell Revenue in Drug Release Platform Business (2020-2025)
7.7.5 MedinCell Recent Development
7.8 Intarcia
7.8.1 Intarcia Company Details
7.8.2 Intarcia Business Overview
7.8.3 Intarcia Drug Release Platform Introduction
7.8.4 Intarcia Revenue in Drug Release Platform Business (2020-2025)
7.8.5 Intarcia Recent Development
7.9 Corium
7.9.1 Corium Company Details
7.9.2 Corium Business Overview
7.9.3 Corium Drug Release Platform Introduction
7.9.4 Corium Revenue in Drug Release Platform Business (2020-2025)
7.9.5 Corium Recent Development
7.10 Enable Injections
7.10.1 Enable Injections Company Details
7.10.2 Enable Injections Business Overview
7.10.3 Enable Injections Drug Release Platform Introduction
7.10.4 Enable Injections Revenue in Drug Release Platform Business (2020-2025)
7.10.5 Enable Injections Recent Development
7.11 Alkermes
7.11.1 Alkermes Company Details
7.11.2 Alkermes Business Overview
7.11.3 Alkermes Drug Release Platform Introduction
7.11.4 Alkermes Revenue in Drug Release Platform Business (2020-2025)
7.11.5 Alkermes Recent Development
7.12 Depomed
7.12.1 Depomed Company Details
7.12.2 Depomed Business Overview
7.12.3 Depomed Drug Release Platform Introduction
7.12.4 Depomed Revenue in Drug Release Platform Business (2020-2025)
7.12.5 Depomed Recent Development
7.13 NanoCarrier
7.13.1 NanoCarrier Company Details
7.13.2 NanoCarrier Business Overview
7.13.3 NanoCarrier Drug Release Platform Introduction
7.13.4 NanoCarrier Revenue in Drug Release Platform Business (2020-2025)
7.13.5 NanoCarrier Recent Development
7.14 Lyndra
7.14.1 Lyndra Company Details
7.14.2 Lyndra Business Overview
7.14.3 Lyndra Drug Release Platform Introduction
7.14.4 Lyndra Revenue in Drug Release Platform Business (2020-2025)
7.14.5 Lyndra Recent Development
7.15 Hisun Pharmaceutical
7.15.1 Hisun Pharmaceutical Company Details
7.15.2 Hisun Pharmaceutical Business Overview
7.15.3 Hisun Pharmaceutical Drug Release Platform Introduction
7.15.4 Hisun Pharmaceutical Revenue in Drug Release Platform Business (2020-2025)
7.15.5 Hisun Pharmaceutical Recent Development
7.16 Livzon Pharmaceutical Group
7.16.1 Livzon Pharmaceutical Group Company Details
7.16.2 Livzon Pharmaceutical Group Business Overview
7.16.3 Livzon Pharmaceutical Group Drug Release Platform Introduction
7.16.4 Livzon Pharmaceutical Group Revenue in Drug Release Platform Business (2020-2025)
7.16.5 Livzon Pharmaceutical Group Recent Development
7.17 Hengrui Pharmaceuticals
7.17.1 Hengrui Pharmaceuticals Company Details
7.17.2 Hengrui Pharmaceuticals Business Overview
7.17.3 Hengrui Pharmaceuticals Drug Release Platform Introduction
7.17.4 Hengrui Pharmaceuticals Revenue in Drug Release Platform Business (2020-2025)
7.17.5 Hengrui Pharmaceuticals Recent Development
7.18 HEC ChangJiang Pharmaceutical
7.18.1 HEC ChangJiang Pharmaceutical Company Details
7.18.2 HEC ChangJiang Pharmaceutical Business Overview
7.18.3 HEC ChangJiang Pharmaceutical Drug Release Platform Introduction
7.18.4 HEC ChangJiang Pharmaceutical Revenue in Drug Release Platform Business (2020-2025)
7.18.5 HEC ChangJiang Pharmaceutical Recent Development
7.19 Luye Pharma
7.19.1 Luye Pharma Company Details
7.19.2 Luye Pharma Business Overview
7.19.3 Luye Pharma Drug Release Platform Introduction
7.19.4 Luye Pharma Revenue in Drug Release Platform Business (2020-2025)
7.19.5 Luye Pharma Recent Development
7.20 Lanna Bio
7.20.1 Lanna Bio Company Details
7.20.2 Lanna Bio Business Overview
7.20.3 Lanna Bio Drug Release Platform Introduction
7.20.4 Lanna Bio Revenue in Drug Release Platform Business (2020-2025)
7.20.5 Lanna Bio Recent Development
8 Drug Release Platform Market Dynamics
8.1 Drug Release Platform Industry Trends
8.2 Drug Release Platform Market Drivers
8.3 Drug Release Platform Market Challenges
8.4 Drug Release Platform Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Drug Release Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drug Release Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Drug Release Platform Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drug Release Platform Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Drug Release Platform Revenue Share by Region (2020-2025)
Table 6. Global Drug Release Platform Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Drug Release Platform Revenue Share Forecast by Region (2026-2031)
Table 8. Global Drug Release Platform Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Drug Release Platform Revenue Market Share by Type (2020-2025)
Table 10. Global Drug Release Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Drug Release Platform Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Drug Release Platform Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Drug Release Platform Revenue Market Share by Application (2020-2025)
Table 15. Global Drug Release Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Drug Release Platform Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Drug Release Platform Application
Table 18. Global Drug Release Platform Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drug Release Platform Market Share by Players (2020-2025)
Table 20. Global Top Drug Release Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Release Platform as of 2024)
Table 21. Ranking of Global Top Drug Release Platform Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drug Release Platform Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drug Release Platform, Headquarters and Area Served
Table 24. Global Key Players of Drug Release Platform, Product and Application
Table 25. Global Key Players of Drug Release Platform, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drug Release Platform Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Drug Release Platform Revenue Market Share by Company (2020-2025)
Table 29. North America Drug Release Platform Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Drug Release Platform Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Drug Release Platform Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Drug Release Platform Revenue Market Share by Company (2020-2025)
Table 33. Europe Drug Release Platform Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Drug Release Platform Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Drug Release Platform Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Drug Release Platform Revenue Market Share by Company (2020-2025)
Table 37. China Drug Release Platform Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Drug Release Platform Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Drug Release Platform Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Drug Release Platform Revenue Market Share by Company (2020-2025)
Table 41. Japan Drug Release Platform Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Drug Release Platform Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Drug Release Platform Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Drug Release Platform Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Drug Release Platform Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Drug Release Platform Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Drug Release Platform Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Drug Release Platform Revenue Market Share by Company (2020-2025)
Table 49. India Drug Release Platform Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Drug Release Platform Market Size by Application (2020-2025) & (US$ Million)
Table 51. Evonik Company Details
Table 52. Evonik Business Overview
Table 53. Evonik Drug Release Platform Product
Table 54. Evonik Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 55. Evonik Recent Development
Table 56. Camurus Company Details
Table 57. Camurus Business Overview
Table 58. Camurus Drug Release Platform Product
Table 59. Camurus Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 60. Camurus Recent Development
Table 61. Pacira BioSciences Company Details
Table 62. Pacira BioSciences Business Overview
Table 63. Pacira BioSciences Drug Release Platform Product
Table 64. Pacira BioSciences Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 65. Pacira BioSciences Recent Development
Table 66. Starpharma Company Details
Table 67. Starpharma Business Overview
Table 68. Starpharma Drug Release Platform Product
Table 69. Starpharma Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 70. Starpharma Recent Development
Table 71. ProLynx Company Details
Table 72. ProLynx Business Overview
Table 73. ProLynx Drug Release Platform Product
Table 74. ProLynx Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 75. ProLynx Recent Development
Table 76. Liquidia Company Details
Table 77. Liquidia Business Overview
Table 78. Liquidia Drug Release Platform Product
Table 79. Liquidia Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 80. Liquidia Recent Development
Table 81. MedinCell Company Details
Table 82. MedinCell Business Overview
Table 83. MedinCell Drug Release Platform Product
Table 84. MedinCell Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 85. MedinCell Recent Development
Table 86. Intarcia Company Details
Table 87. Intarcia Business Overview
Table 88. Intarcia Drug Release Platform Product
Table 89. Intarcia Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 90. Intarcia Recent Development
Table 91. Corium Company Details
Table 92. Corium Business Overview
Table 93. Corium Drug Release Platform Product
Table 94. Corium Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 95. Corium Recent Development
Table 96. Enable Injections Company Details
Table 97. Enable Injections Business Overview
Table 98. Enable Injections Drug Release Platform Product
Table 99. Enable Injections Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 100. Enable Injections Recent Development
Table 101. Alkermes Company Details
Table 102. Alkermes Business Overview
Table 103. Alkermes Drug Release Platform Product
Table 104. Alkermes Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 105. Alkermes Recent Development
Table 106. Depomed Company Details
Table 107. Depomed Business Overview
Table 108. Depomed Drug Release Platform Product
Table 109. Depomed Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 110. Depomed Recent Development
Table 111. NanoCarrier Company Details
Table 112. NanoCarrier Business Overview
Table 113. NanoCarrier Drug Release Platform Product
Table 114. NanoCarrier Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 115. NanoCarrier Recent Development
Table 116. Lyndra Company Details
Table 117. Lyndra Business Overview
Table 118. Lyndra Drug Release Platform Product
Table 119. Lyndra Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 120. Lyndra Recent Development
Table 121. Hisun Pharmaceutical Company Details
Table 122. Hisun Pharmaceutical Business Overview
Table 123. Hisun Pharmaceutical Drug Release Platform Product
Table 124. Hisun Pharmaceutical Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 125. Hisun Pharmaceutical Recent Development
Table 126. Livzon Pharmaceutical Group Company Details
Table 127. Livzon Pharmaceutical Group Business Overview
Table 128. Livzon Pharmaceutical Group Drug Release Platform Product
Table 129. Livzon Pharmaceutical Group Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 130. Livzon Pharmaceutical Group Recent Development
Table 131. Hengrui Pharmaceuticals Company Details
Table 132. Hengrui Pharmaceuticals Business Overview
Table 133. Hengrui Pharmaceuticals Drug Release Platform Product
Table 134. Hengrui Pharmaceuticals Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 135. Hengrui Pharmaceuticals Recent Development
Table 136. HEC ChangJiang Pharmaceutical Company Details
Table 137. HEC ChangJiang Pharmaceutical Business Overview
Table 138. HEC ChangJiang Pharmaceutical Drug Release Platform Product
Table 139. HEC ChangJiang Pharmaceutical Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 140. HEC ChangJiang Pharmaceutical Recent Development
Table 141. Luye Pharma Company Details
Table 142. Luye Pharma Business Overview
Table 143. Luye Pharma Drug Release Platform Product
Table 144. Luye Pharma Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 145. Luye Pharma Recent Development
Table 146. Lanna Bio Company Details
Table 147. Lanna Bio Business Overview
Table 148. Lanna Bio Drug Release Platform Product
Table 149. Lanna Bio Revenue in Drug Release Platform Business (2020-2025) & (US$ Million)
Table 150. Lanna Bio Recent Development
Table 151. Drug Release Platform Market Trends
Table 152. Drug Release Platform Market Drivers
Table 153. Drug Release Platform Market Challenges
Table 154. Drug Release Platform Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Release Platform Product Picture
Figure 2. Global Drug Release Platform Market Share by Type: 2024 VS 2031
Figure 3. Oral Sustained-Release Platform Features
Figure 4. Implantable Sustained-Release Platform Features
Figure 5. Local Sustained-Release Platform Features
Figure 6. Global Drug Release Platform Market Share by Application: 2024 VS 2031
Figure 7. Pharmaceutical Companies
Figure 8. Hospitals
Figure 9. Others
Figure 10. Drug Release Platform Report Years Considered
Figure 11. Global Drug Release Platform Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Drug Release Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug Release Platform Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Asia Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. India Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. South America Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Middle East Drug Release Platform Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Global Drug Release Platform Market Share by Players in 2024
Figure 23. Global Top Drug Release Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Release Platform as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Drug Release Platform Revenue in 2024
Figure 25. North America Drug Release Platform Market Share by Type (2020-2025)
Figure 26. North America Drug Release Platform Market Share by Application (2020-2025)
Figure 27. Europe Drug Release Platform Market Share by Type (2020-2025)
Figure 28. Europe Drug Release Platform Market Share by Application (2020-2025)
Figure 29. China Drug Release Platform Market Share by Type (2020-2025)
Figure 30. China Drug Release Platform Market Share by Application (2020-2025)
Figure 31. Japan Drug Release Platform Market Share by Type (2020-2025)
Figure 32. Japan Drug Release Platform Market Share by Application (2020-2025)
Figure 33. Southeast Asia Drug Release Platform Market Share by Type (2020-2025)
Figure 34. Southeast Asia Drug Release Platform Market Share by Application (2020-2025)
Figure 35. India Drug Release Platform Market Share by Type (2020-2025)
Figure 36. India Drug Release Platform Market Share by Application (2020-2025)
Figure 37. Evonik Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 38. Camurus Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 39. Pacira BioSciences Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 40. Starpharma Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 41. ProLynx Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 42. Liquidia Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 43. MedinCell Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 44. Intarcia Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 45. Corium Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 46. Enable Injections Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 47. Alkermes Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 48. Depomed Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 49. NanoCarrier Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 50. Lyndra Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 51. Hisun Pharmaceutical Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 52. Livzon Pharmaceutical Group Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 53. Hengrui Pharmaceuticals Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 54. HEC ChangJiang Pharmaceutical Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 55. Luye Pharma Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 56. Lanna Bio Revenue Growth Rate in Drug Release Platform Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 10.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Drug Release Platform market?
What was the global market size of Drug Release Platform in 2031?
What is the annual compound growth rate of the global Drug Release Platform market size from 2025 to 2031?
What was the global market size of Drug Release Platform in 2025?
Related Reports
Global Drug Release Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Drug Release Platform market is projected to grow from US$ 2091 million in 2025 to US$ 4089 million by 2032, at a CAGR of 10.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 160
USD 4900.00
(Single User License)
Global Drug Release Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Release Platform market size was US$ 2091 million in 2025 and is forecast to reach a readjusted size of US$ 4089 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 103
USD 4250.00
(Single User License)
Global Drug Release Platform Market Research Report 2026
The global Drug Release Platform market was valued at US$ 2091 million in 2025 and is anticipated to reach US$ 4089 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 130
USD 2900.00
(Single User License)
Drug Release Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Release Platform was estimated to be worth US$ 2091 million in 2025 and is projected to reach US$ 4089 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 139
USD 3950.00
(Single User License)
Global Drug Release Platform Market Research Report 2025
The global market for Drug Release Platform was valued at US$ 1901 million in the year 2024 and is projected to reach a revised size of US$ 3745 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published Date: 2025-08-22
Pages: 97
USD 2900.00
(Single User License)
Drug Release Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Release Platform was estimated to be worth US$ 1901 million in 2024 and is forecast to a readjusted size of US$ 3745 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-08-22
Pages: 138
USD 3950.00
(Single User License)
Global Drug Release Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Release Platform market is projected to grow from US$ 1901 million in 2024 to US$ 3745 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-21
Pages: 152
USD 4900.00
(Single User License)
Global Drug Release Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Drug Release Platform market is projected to grow from US$ 2091 million in 2025 to US$ 4089 million by 2032, at a CAGR of 10.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 160
USD 4900.00 (Single User License)Global Drug Release Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Drug Release Platform market size was US$ 2091 million in 2025 and is forecast to reach a readjusted size of US$ 4089 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 103
USD 4250.00 (Single User License)Global Drug Release Platform Market Research Report 2026
The global Drug Release Platform market was valued at US$ 2091 million in 2025 and is anticipated to reach US$ 4089 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 130
USD 2900.00 (Single User License)Drug Release Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Release Platform was estimated to be worth US$ 2091 million in 2025 and is projected to reach US$ 4089 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 139
USD 3950.00 (Single User License)Global Drug Release Platform Market Research Report 2025
The global market for Drug Release Platform was valued at US$ 1901 million in the year 2024 and is projected to reach a revised size of US$ 3745 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Published: 2025-08-22
Pages: 97
USD 2900.00 (Single User License)Drug Release Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Release Platform was estimated to be worth US$ 1901 million in 2024 and is forecast to a readjusted size of US$ 3745 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-08-22
Pages: 138
USD 3950.00 (Single User License)Global Drug Release Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Release Platform market is projected to grow from US$ 1901 million in 2024 to US$ 3745 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-21
Pages: 152
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now